Literature DB >> 27652206

Prognostic value of wingless-type proteins in non-small cell lung cancer patients: a meta-analysis.

Jiajia Jin1, Ping Zhan2, Hong Qian3, Xiaoxia Wang4, Masaru Katoh5, Kevin Phan6, Jin-Haeng Chung7, Tangfeng Lv2, Yong Song2.   

Abstract

BACKGROUND: Wingless-type protein (Wnt) signaling pathway plays a crucial role in the development of human malignancies, such as epithelial-to-mesenchymal transition (EMT) and the maintenance of cancer stem cells (CSCs). Several studies have shown that the expression levels of Wnt proteins, ligands of Wnt signaling pathway, are related to clinical outcomes of non-small cell lung cancer (NSCLC) patients. This meta-analysis aimed to assess the prognostic value of Wnts proteins in patients with NSCLC.
METHODS: A multiple electronic literature search was conducted to identify all articles referring to the prognostic value of Wnt proteins in patients of NSCLC up to July 2016. Eligible studies were included in a meta-analysis in order to summarize the extracted data in terms of pooled hazard ratios (HRs) and their 95% confidence intervals (95% CIs).
RESULTS: Ten studies published between 2005 and 2015 were eligible for this meta-analysis. The total number of patients included was 1,805. The combined HR for all eligible studies evaluating the overall survival (OS) of NSCLC patients with positive Wnt expression was 1.60 (95% CI: 1.39-1.84). The subgroup analysis showed both Wnt1 and Wnt5a are associated with clinical outcome of NSCLC patients.
CONCLUSIONS: Overexpression of Wnt proteins, as well as Wnt1 or Wnt5a alone, was markedly associated with adverse OS in lung cancer patients, suggesting that Wnts may act as a prognostic marker among NSCLCs.

Entities:  

Keywords:  Meta-analysis; Wingless-type protein (Wnt); non-small cell lung cancer (NSCLC); precision medicine; prognostic significance

Year:  2016        PMID: 27652206      PMCID: PMC5009088          DOI: 10.21037/tlcr.2016.08.08

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN: 2218-6751


  38 in total

Review 1.  Wnt signaling in lung cancer.

Authors:  Julien Mazieres; Biao He; Liang You; Zhidong Xu; David M Jablons
Journal:  Cancer Lett       Date:  2005-05-10       Impact factor: 8.679

2.  Wnt2 promotes non-small cell lung cancer progression by activating WNT/β-catenin pathway.

Authors:  Chongbiao Huang; Ruijue Ma; Yong Xu; Na Li; Zengxun Li; Jie Yue; Haixin Li; Yan Guo; Daliang Qi
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

Review 3.  Non-small cell lung cancer: current treatment and future advances.

Authors:  Cecilia Zappa; Shaker A Mousa
Journal:  Transl Lung Cancer Res       Date:  2016-06

4.  Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer.

Authors:  Cheng-Long Huang; Dage Liu; Jun Nakano; Shinya Ishikawa; Keiichi Kontani; Hiroyasu Yokomise; Masaki Ueno
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

5.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

6.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.

Authors:  David Moher; Larissa Shamseer; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart
Journal:  Syst Rev       Date:  2015-01-01

Review 7.  Wnt Signaling in Cancer Stem Cell Biology.

Authors:  Felipe de Sousa E Melo; Louis Vermeulen
Journal:  Cancers (Basel)       Date:  2016-06-27       Impact factor: 6.639

8.  RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance.

Authors:  David T Miyamoto; Yu Zheng; Ben S Wittner; Richard J Lee; Huili Zhu; Katherine T Broderick; Rushil Desai; Douglas B Fox; Brian W Brannigan; Julie Trautwein; Kshitij S Arora; Niyati Desai; Douglas M Dahl; Lecia V Sequist; Matthew R Smith; Ravi Kapur; Chin-Lee Wu; Toshi Shioda; Sridhar Ramaswamy; David T Ting; Mehmet Toner; Shyamala Maheswaran; Daniel A Haber
Journal:  Science       Date:  2015-09-18       Impact factor: 47.728

9.  Practical methods for incorporating summary time-to-event data into meta-analysis.

Authors:  Jayne F Tierney; Lesley A Stewart; Davina Ghersi; Sarah Burdett; Matthew R Sydes
Journal:  Trials       Date:  2007-06-07       Impact factor: 2.279

10.  Overexpression of Wnt5a promotes angiogenesis in NSCLC.

Authors:  Lingli Yao; Baocun Sun; Xiulan Zhao; Xueming Zhao; Qiang Gu; Xueyi Dong; Yanjun Zheng; Junying Sun; Runfen Cheng; Hong Qi; Jindan An
Journal:  Biomed Res Int       Date:  2014-06-05       Impact factor: 3.411

View more
  9 in total

1.  EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line.

Authors:  Jianxin Tao; Liping Shi; Longchang Huang; Haoze Shi; Hang Chen; Yixin Wang; Tong Wang
Journal:  J Cancer Res Clin Oncol       Date:  2017-07-26       Impact factor: 4.553

Review 2.  TLR/WNT: A Novel Relationship in Immunomodulation of Lung Cancer.

Authors:  Aina Martín-Medina; Noemi Cerón-Pisa; Esther Martinez-Font; Hanaa Shafiek; Antònia Obrador-Hevia; Jaume Sauleda; Amanda Iglesias
Journal:  Int J Mol Sci       Date:  2022-06-11       Impact factor: 6.208

Review 3.  Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies.

Authors:  Yue Zheng; Laduona Wang; Limei Yin; Zhuoran Yao; Ruizhan Tong; Jianxin Xue; You Lu
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

Review 4.  Lung cancer and epithelial-mesenchymal transition.

Authors:  Toshi Menju; Hiroshi Date
Journal:  Gen Thorac Cardiovasc Surg       Date:  2021-03-22

5.  PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway.

Authors:  Ping Zhan; Bin Zhang; Guang-Min Xi; Ying Wu; Hong-Bing Liu; Ya-Fang Liu; Wu-Jian Xu; Qing-Qing Zhu; Feng Cai; Ze-Jun Zhou; Ying-Ying Miu; Xiao-Xia Wang; Jia-Jia Jin; Qian Li; Li-Ping Qian; Tang-Feng Lv; Yong Song
Journal:  Mol Cancer       Date:  2017-06-24       Impact factor: 27.401

6.  miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer.

Authors:  Yong Chen; Lingfeng Min; Chuanli Ren; Xingxiang Xu; Jianqi Yang; Xinchen Sun; Tao Wang; Fang Wang; Changjiang Sun; Xizhi Zhang
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

7.  Emetine Synergizes with Cisplatin to Enhance Anti-Cancer Efficacy against Lung Cancer Cells.

Authors:  Ti-Hui Wu; Shan-Yueh Chang; Yu-Lueng Shih; Tsai-Wang Huang; Hung Chang; Ya-Wen Lin
Journal:  Int J Mol Sci       Date:  2019-11-25       Impact factor: 5.923

Review 8.  Regulation of Wnt Signaling Pathways at the Plasma Membrane and Their Misregulation in Cancer.

Authors:  Yagmur Azbazdar; Mustafa Karabicici; Esra Erdal; Gunes Ozhan
Journal:  Front Cell Dev Biol       Date:  2021-01-21

9.  WNT8B as an Independent Prognostic Marker for Nasopharyngeal Carcinoma.

Authors:  Chawalit Ngernsombat; Pongphol Prattapong; Noppadol Larbcharoensub; Krittika Khotthong; Tavan Janvilisri
Journal:  Curr Oncol       Date:  2021-07-08       Impact factor: 3.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.